A Novel Gene Underlies Bleomycin-Response Variation in Caenorhabditis elegans

Bleomycin is a powerful chemotherapeutic drug used to treat a variety of cancers. However, individual patients vary in their responses to bleomycin. The identification of genetic differences that underlie this response variation could improve treatment outcomes by tailoring bleomycin dosages to each...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Genetics
Prif Awduron: Brady, Shannon C., Zdraljevic, Stefan, Bisaga, Karol W., Tanny, Robyn E., Cook, Daniel E., Lee, Daehan, Wang, Ye, Andersen, Erik C.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Genetics Society of America 2019
Pynciau:
Investigations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6707474/
https://ncbi.nlm.nih.gov/pubmed/31171655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1534/genetics.119.302286
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg